relios.vision GmbH, a University of Bonn start-up that has developed the SmartContrast software, receives funding from the European Innovation Council’s (EIC) Women TechEU program. Experts from the fields of medicine and mathematics are involved in the company. Using artificial intelligence, SmartContrast aims to lower the use of contrast agents for magnetic resonance imaging of the brain, thus reducing examination costs and potential risks for patients and the environment.
To mark World Day for Laboratory Animals, the Faculty of Agriculture at the University of Bonn ran a fact-finding event on animal testing for its students.
What possibilities does mRNA technology offer? How can we use computers to answer biomedical questions? And how does what I eat affect my immune system? The ImmunoSensation2 Cluster of Excellence at the University of Bonn will be celebrating the International Day of Immunology in Bonn’s city center on April 29. On Marktplatz, researchers will be providing a personal insight into their work and will be on hand from 10 am to 6 pm to chat with locals and answer their questions. At Bonn City Library, meanwhile, selected topics from the field of biomedicine will be showcased in more detail between 11 am and 2 pm. Admission is free at both venues.
On the occasion of World Day for Laboratory Animals, researchers of the 3R Competence Network NRW explain how animal experimentation can be improved and why it is still necessary.
Mathematical modelling and analysis are essential for all fields of the life sciences nowadays, ranging from basic research to clinical application. The collaboration between mathematicians and life scientists has a long tradition in Bonn. This week Bonn researchers exchange views with colleagues from Germany and abroad on the current status and possible future developments at an international conference at the Wissenschaftszentrum Bonn.
Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options. Researchers at the University Hospital Bonn (UKB) have now been able to elucidate a mechanism underlying cisplatin resistance in testicular cancer. Using CRISPR gene scissors, they identified the NAE1 gene as its driver. Inhibiting this resistance mediator by adding the NAE1 inhibitor MLN4924 not only restores the effect of cisplatin, but also has an additional killing effect on tumor cells. The study results have now been published in the British Journal of Cancer.
The members of the recently newly elected University Council of the University of Bonn have been handed their appointment certificates for their 2023–2028 term of office by Gonca Türkeli-Dehnert, State Secretary in the Ministry of Culture and Science of the state of North Rhine-Westphalia. At the inaugural meeting following the presentation, the University Council re-elected Prof. Dr. Dieter Engels, former President of the Federal Court of Auditors, as its Chairperson. Prof. Engels has chaired the body since as long ago as 2013.
The research group led by Dr. Laura Surace at the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn has received funding from the German Cancer Aid through the Max Eder Junior Research Group Program. The program was established to specifically support the research of up-and-coming young oncologists. This is intended to benefit not only the field of oncology, but also the training of the researchers. Surace joins a group of around 30 young scientists who are being supported throughout Germany.